IAC regimen: Difference between revisions
Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}} Idarubicin-Adriamycin-Cladribine regimen ==Overview== {{PAGENAME}} refers to a regimen consisting of idarubicin, doxorub..." |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AV}} | {{CMG}}; {{AE}} {{AV}} | ||
{{SK}} Idarubicin- | {{SK}} Idarubicin-Cytarabine-Cladribine regimen | ||
==Overview== | ==Overview== | ||
{{PAGENAME}} refers to a regimen consisting of [[idarubicin]], [[ | {{PAGENAME}} refers to a regimen consisting of [[idarubicin]], [[Cytarabine|cytarabine (Ara-C)]], and [[cladribine]] used to treat [[acute myelogenous leukemia]]. | ||
==Regimen== | ==Regimen== | ||
{{chemo|I|Idrarubicin}} | {{chemo|I|Idrarubicin}} | ||
{{chemo|A| | {{chemo|A|Cytarabine (Ara-C)}} | ||
{{chemo|C|Cladribin}} | {{chemo|C|Cladribin}} |
Revision as of 13:36, 27 March 2015
WikiDoc Resources for IAC regimen |
Articles |
---|
Most recent articles on IAC regimen Most cited articles on IAC regimen |
Media |
Powerpoint slides on IAC regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on IAC regimen at Clinical Trials.gov Clinical Trials on IAC regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on IAC regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on IAC regimen Discussion groups on IAC regimen Patient Handouts on IAC regimen Directions to Hospitals Treating IAC regimen Risk calculators and risk factors for IAC regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for IAC regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: Idarubicin-Cytarabine-Cladribine regimen
Overview
IAC regimen refers to a regimen consisting of idarubicin, cytarabine (Ara-C), and cladribine used to treat acute myelogenous leukemia.
Regimen
IIdrarubicin
ACytarabine (Ara-C)
CCladribin